论文部分内容阅读
生物医药行业是一个新兴的高新技术产业,且发展迅速,是技术和资金密集型发展中的佼佼者。较高的技术要求、高投入、高回报、高风险是其特点,行业内很多企业都对融资有着十分迫切的要求。这主要因生物医药的研发需要的周期长,新生技术和药物的研制一般都要经历研发和实验等多种阶段,数年、甚至十年的累积才能获得成效,整个研发过程都需要源源不断的资金、技术、人力的投入。因此,医药企业必须将自身的融资渠道不断扩大,对自身存有的融资机制进行健全,融资结构进行完善调整,其对生物医药企业的生存和发展具有重要的理论指导和借鉴意义。
The biomedical industry is an emerging high-tech industry that has grown rapidly and is a leader in technology and capital-intensive development. High technical requirements, high input, high return, high risk is its characteristics, many companies in the industry have very urgent requirements for financing. This is mainly due to the long period needed for biomedical research and development. The development of new technologies and pharmaceuticals generally needs to go through various stages of research and development and experimentation. Only a few years or even ten years can cumulative results be achieved. The entire R & D process requires a steady stream of Capital, technology, human input. Therefore, pharmaceutical companies must expand their own financing channels, make sound adjustments to their existing financing mechanisms and optimize the financing structure, which has important theoretical guidance and reference significance for the survival and development of biomedical enterprises.